No Data
No Data
Immix Biopharma Announces Dr. Raymond Comenzo, Internationally Recognized AL Amyloidosis Expert, Director of the Myeloma and Amyloid Program at Tufts Medical Center, Joins Scientific Advisory Board
Express News | Immix Biopharma Announces DR. Raymond Comenzo, Internationally Recognized Al Amyloidosis Expert, Director of the Myeloma and Amyloid Program at Tufts Medical Center, Joins Scientific Advisory Board
Immix Biopharma Independent Director Acquires 2.6% More Stock
Jason Hsu Bought 2.6% More Shares In Immix Biopharma
Sector Update: Health Care Stocks Ease in Afternoon Trading
Immix Biopharma Expands US Nexicart-2 Trial for AL Amyloidosis With 3 Clinical Sites
No Data
No Data